HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (1- acetyl- 4- methyl- 4- phenyl- 1,2,3,4- tetrahydro- quinolin- 6- yl)- 3- (3- trifluoromethyl- phenyl)propionamide

structure in first source

Also Known As:

Org 274179-0; Org-274179-0

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Aminoquinolines: 29
        N-(1-acetyl-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-3-(3-trifluoromethyl-phenyl)propionamide: 1

Experts

1.	Boelen, Anita: 1 article (05/2012)
2.	Conti, Paolo: 1 article (05/2012)
3.	Fliers, Eric: 1 article (05/2012)
4.	Karstens, Willem-Jan: 1 article (05/2012)
5.	Miltenburg, André M M: 1 article (05/2012)
6.	Plate, Ralf: 1 article (05/2012)
7.	Saeed, Peerooz: 1 article (05/2012)
8.	Surovtseva, Olga V: 1 article (05/2012)
9.	Timmers, Marco: 1 article (05/2012)
10.	Wiersinga, Wilmar M: 1 article (05/2012)

Related Diseases

1.	Graves Ophthalmopathy 05/01/2012 - "In the present study, we tested whether the novel low-molecular-weight (LMW) TSHR antagonist Org-274179-0 inhibits cAMP production induced by rhTSH, Graves' disease IgG (GD-IgG), or M22 (a potent human monoclonal TSHR stimulating antibody) in cultured and differentiated OF from Graves' ophthalmopathy patients. "
2.	Graves Disease (Basedow Disease) 05/01/2012 - "In the present study, we tested whether the novel low-molecular-weight (LMW) TSHR antagonist Org-274179-0 inhibits cAMP production induced by rhTSH, Graves' disease IgG (GD-IgG), or M22 (a potent human monoclonal TSHR stimulating antibody) in cultured and differentiated OF from Graves' ophthalmopathy patients. "

Related Drugs and Biologics

1.	Thyrotropin Alfa
2.	Immunoglobulin G (IgG)
3.	gadolinium-IGG complex